Feasibility of intravitreal erythropoietin injections in humans.

Abstract

BACKGROUND/AIMS Preclinical data suggest that intravitreally administered erythropoietin (EPO) is both neuroprotective and safe. In a small pilot series, we intended to assess the feasibility of intravitreal EPO injections in humans. METHODS Three patients with acute vascular occlusion of the posterior pole received a single intravitreal EPO injection of… (More)
DOI: 10.1136/bjo.2008.156794

Topics

  • Presentations referencing similar topics